In SLE studies, CD74 was identified as a marker of exhausted regulatory CD4+T cell subset that contribute to SLE pathogenesis and showed therapeutic potential when blocked or knocked out in SLE animal models [10, 58, 59]. Here, CD74 is linked to systemic lupus erythematosus.